In this segment, members of the Pharmaceutical CEO Leadership: Diversity in Pharma panel reveal how diversity extends beyond their own walls. Choosing partners with common values and goals demonstrates their commitment. Being proactive in society, for example by encouraging minority groups to get involved in pharma in order to build a diverse talent pipeline, will highlight them as leaders in this mission.
In this segment, members of the Pharmaceutical CEO Leadership Image of the Pharma Industry panel discuss the benefits of collaboration, both internally and externally, to advance the greater mission of the pharma industry.
In this segment, members of the Pharmaceutical CEO Leadership Image of the Pharma Industry panel discuss connecting with patients and keeping their perspective and best interests in mind when making decisions to uphold the industry’s commitment and responsibility to improving people’s lives.
In this segment, members of the Pharmaceutical CEO Leadership Image of the Pharma Industry panel discuss how educating the general population about the value of pharma’s many life-changing therapies can provide a deeper understanding of and appreciation for what pharma does.
In this segment, members of the Pharmaceutical CEO Leadership Image of the Pharma Industry panel discuss the importance of showing employees that they are valued, especially during a pandemic, through increased support, communication, transparency, and trust.
From COVID day-to-day management, to the future of the workforce In this segment, members of the, Pharmaceutical CEO Leadership During the Pandemic panel discuss the first order of business when restrictions began to how they envision employee safety and operations in the future.
Associate Editor, Christen Harm talks with Peter Barschdorff, Vice President, Commercial Insights, GSK , at the 2019 18th Annual eyeforpharma Philadelphia Conference, Expo & Awards.
Greg Apostol, National Vice President, Key Account Management, Alkermes, talks with Pharm Exec's Editorial Director Lisa Henderson, at the 2019 18th Annual eyeforpharma Philadelphia Conference, Expo & Awards.
David Van Sickle, CEO, Propeller Health, talks with Pharm Exec's European Editor, Julian Upton, at the 2019 17th Annual Patient Engagement eyeforpharma Barcelona event about how the digital therapeutics landscape has changed.
New Jersey is still a top pick for companies when it comes to pharma.
Enzychem Lifesciences explains why the Korean biotech decided to open U.S. headquarters, as well as gives an update on their most recent clinical trials.
Hear what Sanofi looks for when they decide to form a partnership with another company.
Otsuka Pharmaceutical’s President and CEO of Development and Commercialization William Carson explains the initial growing pains the company went through with their technology company partner in the early development stages of the first U.S. FDA approved digital medicine system.
William Carson, president & CEO of Otsuka Pharmaceutical’s development and commercialization, talks about the challenges facing the pharmaceutical industry when it comes to the massive amounts of data being collected.
Take a sneak peek at what the future of home healthcare could look like with the use of robotics and artificial intelligence.
The pharmaceutical industry needs to be paying more attention to consumer purchase habits.
Albert Thigpen, president and chief operating officer of CastiaRx, talks about how pharmaceuticals companies could be using devices such as Amazon’s Alexa to help improve patient adherence and the overall patient journey.His remarks come after a seminar at Asembia’s Specialty Pharmacy Summit in Las Vegas.
John Cervione, managing partner of Blue Fin Group, talks briefly about Amazon’s foray into the healthcare and pharma industries.
Jennifer Miller talks about about pharma's reputation problem.
